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Abstract 
 The global prevalence of dengue cases has increased in India. The increasingly 
widespread distribution and the rising incidence of dengue virus infections are related to 
increased distribution of Aedes aegypti, an increasingly urban population, and increasing air 
travel. Several countries show that the age of the reported dengue cases has increased from 5-
12 years, to older children and young adults. Although shock and plasma leakage seem to be 
more prevalent as age decreases, the frequency of internal hemorrhage rises as age increases. 
Increase in liver enzymes found in both children and adults indicated liver involvement during 
dengue infections. Pre-existing liver diseases in adults such as chronic hepatitis, alcoholic 
cirrhosis, and hemoglobinopathies may aggravate the liver impairment in dengue infection. 
Fulminant hepatitis is a rare but well described problem in adult patients with dengue infection. 
Currently, no specific therapeutic agent exists for dengue. The early recognition of dengue 
infection, bleeding tendency, and signs of circulatory collapse would reduce mortality rates in 
adult patients with dengue infection. 
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INTRODUCTION 
Dengue fever (DF) and dengue 
hemorrhagic fever (DHF) are re-emerging 
mosquito-borne viral infections caused by 
four closely related dengue viruses 
(serotypes 1-4) of the genus Flavivirus. 
These dengue viruses are by the Aedes 
aegypti and Ae. albopictus mosquito 
species. The dengue virus has antigenically 
similar but immunologically distinct 
serotypes. Infection confers lifelong 
immunity to the infecting serotype 
therefore; a person can be infected with 
dengue virus up to four times during his or 
her lifetime. The World Health 
Organization (WHO) predicted that there 
are more than 2.5 billion people living in 
tropical and subtropical countries, mostly in 
large and small cities, at risk of dengue 
infection with one or more dengue viruses.. 
Ideal conditions for increased transmission 
of dengue virus in tropical urban centres 
have been created by substandard housing 
and crowding, as well as deterioration in 
water, sewer, and waste management 
systems, all of which are intimately 
associated with unplanned urbanization 
(Barbazan et al, 2002; Guzman and Kouri, 
2003; Nakhapakorn and Tripathi, 2005; 
Anyamba et al, 2006). Without an effective 
vaccine or antiviral agent, an effective 
vector control program is the only means to 
reduce dengue infection in endemic areas. 
The age distribution is different in the 
places in India, where these syndromes 
occur in all age groups. Several Asian 
countries have shown that age of the 
reported dengue cases has increased from 
5-12 years to older children and young 
adults (Charoensook et al, 1999; 
Pancharoen et al, 2002; Pongsumpun et al, 
2002; Kulanatne et al, 2005). The affected 
adults aged over 15 years old are reported 
to comprise 20%-40% of dengue virus 
infected cases according to the 
Epidemiological Surveillance System 
(Patumanond et al, 2003; Department of 
Epidemiology, 2012). Morbidity and 
mortality rates of dengue have been highest 
in children, especially in the 5-9 year age 
group. At present, the morbidity rate of 
DHF has declined to 0.15% while the 
average age of dengue patients is 
increasing. 
CLINICAL MANIFESTATION  
In the early stage of dengue infection, diag-
nosis from clinical manifestation alone is 
difficult, especially in adults. Dengue has 
numerous differential diagnoses, including 
malaria, leptospirosis, rickettsial diseases, 
typhoid, chikungunya, other viral hemor-
rhagic disease, and so forth (Leelarasamee 
et al, 2004; Phuong et al, 2006). Dengue 
infection should be suspected if the patients 
have a fever of 10 days or less with myalgia, 
Journal of Advanced Applied Scientific Research - ISSN: 2454-3225  
S.Lalitha et.al JOAASR-RTB-2016- February-2016:67-73  
 
69 
 
arthralgia, bone pain, headache, peri-orbital 
pain, flushing, nausea or vomiting with no 
obvious respiratory tract symptoms or signs 
and no organ specific symptoms of other 
infectious diseases. After an incubation 
period of 4 to 7 days, the febrile period is 
accompanied by severe headache, retro-
orbital pain, myalgia, arthralgia, nausea, 
and vomiting. Tantawichien et al (2000) 
described the clinical manifestations of 
adult patients infected with dengue virus 
during the epidemic of dengue infection 
and he reported that there was fever (3 to 8 
days), nausea/vomiting, headache, and 
myalgia in both DF and DHF; however 
abdominal pain and severe or widespread 
bleeding manifestations were less frequent 
in DF.  
 The tourniquet test has been used as 
a clue for dengue infection for a long time 
and has been considered by the WHO in 
2009 as one of the criteria for probable 
dengue infection. Unfortunately, the 
sensitivity and specificity of tourniquet test 
from previous report, especially in children, 
were not excellent, ranging between 34%-
56% and 68%-94%, respectively. However, 
this test was regarded to be a cheap and 
simple clinical method that is suggestive of 
dengue when positive, but a negative test 
does not exclude the disease (Phuong et al, 
2002; Gregory et al, 2011; Mayxay et al, 
2011; Halsey et al, 2013). 
LABORATORY TESTS 
The test such as reverse transcription 
polymerase chain reaction (RT-PCR) or 
dengue non-structural protein 1 antigen, 
capture assay (NS1 Ag assay) are usually 
used to diagnose the dengue infection 
antigen during the early phase of acute 
infection, and serological ELISA is used to 
detect specific IgM or IgG antibodies. DF is 
usually a self-limiting condition, and death 
as a result is uncommon. Nevertheless, 
patients who have severe nausea/vomiting, 
severe hemorrhage (for example, 
hematemesis, hematochezia, or abnormal 
vaginal bleeding), hypotension, a platelet 
count of ≤20,000/mm3 (≤20x109/l), AST 
or ALT >500 U/ml, renal failure, liver 
failure, heart failure, drowsiness, severe 
hypoxemia, pregnancy, and no opportunity 
to be followed up in an out-patient setting 
should be hospitalized. Adults may be at 
lower risk of developing DHF compared to 
children and adolescent due to differences 
in capillary permeability (Gamble et al, 
2000). During the transition from the febrile 
to afebrile phase, DHF patients with 
increased capillary permeability may 
manifest with the warning signs, mostly as 
a result of plasma leakage. The cardinal 
features that distinguish DHF from DF are 
increased vascular permeability (plasma 
leakage syndrome), and marked 
thrombocytopenia (< 100 x109/l) 
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associated with bleeding and hepatomegaly 
and/or abnormal liver function (WHO, 
1997). 
DIAGNOSIS 
Early definite diagnosis of dengue infection 
can help clinicians in initiation of early 
supportive care, adequate management, and 
identification of patients with severe 
dengue, who should be close monitored for 
signs of plasma leakage, bleeding, and end 
organ damage. This information might 
promote early supportive therapies, prevent 
the use of potentially harmful drugs, 
encourage assessment of complications, 
ensure the adequate use of treatment 
guidelines, and lead to the effective control 
of dengue outbreaks. Laboratory diagnosis 
of dengue infection is established either 
directly by isolation or detection of viral 
components in serum or tissue, or indirectly 
by detection of virus-specific antibodies in 
human serum (Poerscha et al, 2005). The 
sensitivity of each approach is influenced 
by the duration and severity of the patient’s 
illness. It should be stressed that in dengue 
endemic areas, while early accurate 
laboratory tests are not widely available, 
dengue infection should be considered in 
every patient presenting with an acute 
undifferentiated febrile illness. However, 
monitoring all these patients for the 
development of warning signs of severity 
may impose a great burden on healthcare 
services. In the very early stage of illness 
when patients generally seek medical 
attention within the first 2-to-3 days of 
fever without specific symptoms, only RT-
PCR or dengue virus NS1 Ag assay can 
reliably confirm the diagnosis of dengue. 
RT-PCR is definitely the most satisfactory 
test that might detect dengue viruses up to 
the seventh day after the onset of the 
symptoms, especially in severe cases 
(Yamada et al, 2002; Lanciotti, 2003). In 
addition, the presence of dengue virus in 
frozen and fixed tissues, saliva or urine can 
be determined by RT-PCR. As an early 
supportive care, adequate management, and 
identification of patients with severe 
dengue, who should be closely monitored 
for signs of plasma leakage, bleeding, and 
end organ damage. Laboratory diagnosis of 
dengue infection is established either 
directly by isolation or detection of viral 
components in serum or tissue, or indirectly 
by detection of virus-specific antibodies in 
human serum (Poerscha et al, 2005). The 
sensitivity of each approach is influenced 
by the duration and severity of the patient’s 
illness. It should be stressed that in dengue 
endemic areas, while early accurate 
laboratory tests are not widely available, 
dengue infection should be considered in 
every patient presenting with an acute 
undifferentiated febrile illness.  
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However, monitoring all these patients for 
the development of warning signs of 
severity may impose a great burden on 
healthcare services. In the very early stage 
of illness when patients generally seek 
medical attention within the first 2-to-3 
days of fever without specific symptoms, 
only RT-PCR or dengue virus NS1 Ag 
assay can reliably confirm the diagnosis of 
dengue. RT-PCR is definitely the most 
satisfactory test that might detect dengue 
viruses up to the seventh day after the onset 
of the symptoms, especially in severe cases 
(Yamada et al, 2002; Lanciotti, 2003). In 
addition, the presence of dengue virus in 
frozen and fixed tissues, saliva or urine can 
be determined by RT-PCR.  
TREATMENT AND PREVENTION   
The early recognition of dengue infection, 
bleeding tendency, signs of circulatory 
collapse, and complications would reduce 
mortality rates in adult patients with dengue 
infection. Mild dengue infections may be 
treated at home with oral hydration and 
antipyretics with instructions to return to 
the hospital immediately if bleeding or 
warning signs suggestive of severe disease 
develop. Oral rehydration is indicated to 
replace losses from vomiting and high 
fever. It is necessary to avoid the use of 
salicylates, NSAIDs, and traditional 
medicines that may contain hepatotoxic 
agents. Development of any warning sign 
(eg, severe vomiting, gastrointestinal 
haemorrhage, hypotension, high liver 
transaminase, acute renal impairment, 
alteration of consciousness, severe 
thrombocytopenia, etc) indicates the need 
for hospitalization and close observation 
with appropriate use of parenteral fluids in 
patients with inadequate oral intake or a 
rapidly increasing haematocrit. Attentive 
clinical monitoring of patients with severe 
dengue or suspected DHF-DSS and 
anticipatory and supportive care are life-
saving and have reduced fatality rates. 
WHO recommends immediate volume 
replacement with Ringer’s lactate, or 
physiologically normal saline solution, 
followed by fresh frozen plasma or colloid 
solutions such as albumin, or dextran in the 
event that shock persists. Crystalloid 
solutions should be used initially, and 
isotonic colloid solutions should be 
reserved for patients presenting with 
profound shock or those who do not have a 
response to initial crystalloid therapy. 
Recently, two randomized controlled trials 
evaluated therapeutic responses to colloid 
and crystalloid solutions (Dung et al, 1999; 
Wills et al, 2005; Akech et al, 2011). 
RESULTS  
Ringer’s lactate performed the least well 
and that the more severely ill patients 
identified by a narrow pulse pressure (≤10 
mmHg) would benefit more from initial 
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resuscitation with colloid solution than with 
crystalloid solution. Whole blood, platelet, 
and fresh-frozen plasma transfusions can be 
lifesaving for patients with severe bleeding 
that compromises cardiovascular function, 
but it should be undertaken with care 
because of the risk of fluid overload. The 
use of prophylactic blood or platelet 
transfusions may be harmful and should be 
avoided, and invasive procedures should be 
minimized to avoid hemorrhagic 
complications. Currently, there is no 
evidence to support the use of any 
adjunctive therapies such as corticosteroid, 
desmopressin, or carbazochrome sodium 
sulfonate for dengue infection. Dengue 
prevention currently relies on public health 
and community-based Aedes aegypti 
control programs to remove and destroy 
mosquito-breeding sites. The most 
advanced approach is a potential vaccine 
consisting of a tetravalent combination of 
attenuated dengue strains, and other 
approaches are undergoing initial clinical 
evaluation. Dengue will continue to spread 
worldwide until a safe and effective vaccine 
is available alongside sustainable mosquito 
control practices. 
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